You are here:

NICE
NICE Guidance
Conditions and diseases
Cystic fibrosis

Mannitol dry powder for inhalation for treating cystic fibrosis

Technology appraisal guidance
Reference number: TA266
Published: 28 November 2012

Guidance
Tools and resources
Information for the public
Evidence
History

Cystic fibrosis - mannitol: Pharmaxis

Cystic fibrosis - mannitol: Pharmaxis

Cystic fibrosis - mannitol: Pharmaxis
26 October 2012
(3 Mb 54 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 24 October 2012